Farrell Simon Trevi Therapeutics, Inc. (TRVI) insider trading activity

TRVI Quotes by TradingView

Farrell Simon is Chief Commercial Officer of Trevi Therapeutics, Inc.. Currently has a direct ownership of 76,900 shares of TRVI, which is worth approximately $499,850. The most recent transaction as insider was on Mar 10, 2025, when has been sold 81,313 shares (Common Stock) at a price of $6.94 per share, resulting in proceeds of $564,312. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 76.9K
68.46% 3M change
68.46% 12M change
Total Value Held $499,850

Farrell Simon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2025
SELL
Open market or private sale
$564,312 $6.94 p/Share
81,313 Reduced 51.39%
76,900 Common Stock
Mar 10 2025
BUY
Exercise of conversion of derivative security
$285,910 $2.54 p/Share
112,563 Added 41.57%
158,213 Common Stock
Jun 20 2023
BUY
Exercise of conversion of derivative security
$3,187 $0.51 p/Share
6,250 Added 12.04%
45,650 Common Stock
Mar 07 2023
BUY
Exercise of conversion of derivative security
$9,562 $0.51 p/Share
18,750 Added 32.24%
39,400 Common Stock
FS

Farrell Simon

Chief Commercial Officer
New Haven, CT

Track Institutional and Insider Activities on TRVI

Follow Trevi Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRVI shares.

Notify only if

Insider Trading

Get notified when an Trevi Therapeutics, Inc. insider buys or sells TRVI shares.

Notify only if

News

Receive news related to Trevi Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TRVI